Vascular endothelial growth factor expression in oligodendrogliomas: A correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival

Neuropathology and Applied Neurobiology

Volumn 26, Issue 4, 2000, Pages 379-389

  Varlet, P ^a   Guillamo, J S ^a   Nataf, F ^b   Koziak, M ^b   Beuvon, F ^a   Fallet, C ^a   Daumas Duport, C ^a  

^a Dept of Pathology Neurooncology ^*  (France)

^b CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

MIB 1; Oligodendroglioma; Prognosis parameter; Survival; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, NUCLEAR; BRAIN NEOPLASMS; CELL DIVISION; DISEASE-FREE SURVIVAL; ENDOTHELIAL GROWTH FACTORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHOKINES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; OLIGODENDROGLIOMA; PROPORTIONAL HAZARDS MODELS; STATISTICS; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033867473     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2000.00263.x     Document Type: Article

References (37)

1. 1 Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JP, Rosenblum ML. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 1998; 88: 513-20
2. 2 Bello L, Righini A, Marras C et al. In vivo measurement of angiogenesis in gliomas: preliminary results (Abstract). J Neurooncol 1998; 39: 100
3. 3 Berkman RA, Merrill MJ, Reinhold WC et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 1993; 91: 153-9
4. 4 Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryogenic angiogenesis and endothelial cell differentiation. Development 1992; 114: 521-32
5. 5 Chan AS, Leung SY, Wong MP et al. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma. Am J Surg Pathol 1998; 22: 816-26
6. 6 Christov C, Adle-Biassette H, Le Guerinel C, Natchev S, Gherardi RK. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas. Neuropathol Appl Neurobiol 1998; 24: 29-35
7. 7 Conolly DT, Heuvelman DM, Nelson R et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-8
8. 8 Coons SW, Johnson PC, Pearl DK. The prognostic significance of Ki 67 labeling indices for oligodendrogliomas. Neurosurgery 1997; 41: 878-85
9. 9 Daumas-Duport C, Monsaingeon V, Blond S, Munari C, Musolino A, Chodkiewicz JP. Serial stereotactic biopsies and CT scan in gliomas: correlative study in 100 astrocytomas, oligo-astrocytomas and oligodendrocytomas. J Neurooncol 1986; 4: 317-28
10. 10 Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP. Oligodendrogliomas. Part 1: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol 1997; 34: 37-59
11. 11 Daumas-Duport C, Tucker ML, Kolles H et al. Oligodendrogliomas. Part 2: a new grading system based on morphological and imaging criteria. J Neurooncol 1997; 34: 61-78
12. 12 Ferrara N, Winer J, Burton T et al. Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest 1993; 91: 160-70
13. 13 Ferrera N. Vascular endothelial growth factor. Eur J Cancer 1996; 32: 2413-22
14. 14 Ferrera N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25
15. 15 Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6
16. 16 Folkman J, Klagsbrun N. Angiogenesic factors. Science 1987; 235: 442-7
17. 17 Going JJ. Efficiently estimated histologic cell counts. Hum Pathol 1994; 25: 333-6
18. 18 Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-64
19. 19 Hatva E, Kaipainen A, Mentula P et al. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 1995; 146: 368-78
20. 20 Heegaard S, Sommer HM, Broholm H, Broendstrup O. Proliferating cell nuclear antigen and KI-6 7 immunohistochemistry of oligodendrogliomas with special reference to prognosis. Cancer 1995; 76: 1809-13
21. 21 Keck PJ, Hauser S, Krivi G et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309-12
22. 22 Kelly PJ, Daumas-Duport C, Scheithauer BW, Kall BA, Kispert DB. Stereotactic histologic correlations of computed tomography and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987; 62: 450-9
23. 23 Kieser A, Weich HA, Brandner G, Marmé D, Kolch W. Mutant P53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994; 9: 963-9
24. 24 Kim KJ, Li B, Winer J, Armanini M, Gillett N, Philipps HS, Ferrara N. Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in vivo. Nature 1993; 362: 841-4
25. 25 Kros JM, Hop WC, Godschalk JJ, Krishnadath KK. Prognostic value of the proliferation-related antigen Ki 67 in oligodendrogliomas. Cancer 1996; 78: 1107-13
26. 26 Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-9
27. 27 Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991; 351: 453-6
28. 28 Pietsch T, Valter MM, Wolf HK et al. Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol 1997; 93: 109-17
29. 29 Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-8
30. 30 Plate KH, Breier G, Risau W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 1994; 4: 207-18
31. 31 Plate KH, Breier G, Weich HA, Mennel HD, Risau W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 1994; 59: 520-9
32. 32 Plate KH, Risau W. Angiogenesis in malignant gliomas. Glia 1995; 15: 339-47
33. 33 Plate KH. Mechanisms of angiogenesis in the brain. J Neuropathol Exp Neurol 1999; 58: 313-20
34. 34 Samoto K, Ikezaki K, Ono M et al. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 1995; 55: 1189-93
35. 35 Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-5
36. 36 Weindel K, Moringlane JR, Marme D, Weich HA. Detection and quantification of vascular endothelial growth factor / vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? Neurosurgery 1994; 35: 439-49
37. 37 Wharton SB, Hamilton FA, Chan WK, Chan KK, Anderson JR. Proliferation and cell death in oligodendrogliomas. Neuropathol Appl Neurobiol 1998; 24: 21-8